News
Guides, lab handling, storage and research insights from our team.
dual agonist
Aug 28, 2026
Retatrutide vs Tirzepatide for Type 2 Diabetes RemissionRetatrutide and tirzepatide may influence type 2 diabetes remission through distinct receptor actions. This article compares their mechanisms, evidenceRead article
alcohol cravings
Aug 12, 2026
Retatrutide and Alcohol Cravings: Can the Triple-Agonist Outperform Tirzepatide?Retatrutide, a triple-agonist peptide, is being explored for alcohol cravings, but it lacks FDA approval. Could it outperform tirzepatide? Evidence...Read article